Effects of a Supplement on Acute Respiratory Infections

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Respiratory Tract Infection
Interventions
DIETARY_SUPPLEMENT

Omniplus Supreme

Two dietitians prepared the products (one preparer per product) by dissolving two envelopes of 20 ml of the product in 240 ml of water in a disposable cup, every day from Monday to Saturday during the intervention period (90 days of actual consumption). In order to maintain blinding, these dietitians then gave the prepared cups to two different supervisors who in turn gave the product to each participant for consumption (once-daily doses). The preparation and delivery of the product was carried out during two work shifts (morning and afternoon), depending on each participants work schedule. The supervisors recorded product administration and consumption for each participant on a control form.

OTHER

Placebo

A product with maltodextrins, flavors and colorants without vitamins, minerals and plant extracts. Two dietitians prepared the products (one preparer per product) by dissolving two envelopes of 20 ml of the product in 240 ml of water in a disposable cup, every day from Monday to Saturday during the intervention period (90 days of actual consumption). In order to maintain blinding, these dietitians then gave the prepared cups to two different supervisors who in turn gave the product to each participant for consumption (once-daily doses). The preparation and delivery of the product was carried out during two work shifts (morning and afternoon), depending on each participants work schedule. The supervisors recorded product administration and consumption for each participant on a control form.

Trial Locations (1)

44500

Omnilife, Guadalajara

All Listed Sponsors
collaborator

University of Guadalajara

OTHER

lead

Omnilife Manufactura, SA de CV

INDUSTRY

NCT02210156 - Effects of a Supplement on Acute Respiratory Infections | Biotech Hunter | Biotech Hunter